Friday, 1 March 2019

Activist investor Starboard Value says it will oppose Bristol-Myers' $74 billion deal for Celgene

The activist investor says it intends to use its stake in Bristol-Myers Squibb to oppose its acquisition of Celgene.

from Health and Science https://ift.tt/2GRSUvf

No comments:

Post a Comment